how does semaglutide help with pcos Rising use of GLP-1 medications among women Ozempic (Semaglutide) for PMOS/PCOS: Pelvic
Description
Over weeks and months this can nudge daily calorie intake down and support small weight loss

Studies using single-cell RNA-sequencing show that Gipr is expressed in various cell types, including neurons, oligodendrocytes, mesenchymal cells and pericyte and tanycyte mural cells 10,11,12

Clinical trials indicate promising results, with participants experiencing significant weight loss and improvements in body composition
When used together, both mechanisms engage simultaneously, creating a synergistic glucose-lowering effect that can lead to excessive drops below target range

doi: 10.1038/s41586-022-05266-z 21 McIntyreR

Female patients make up nearly 65% of GLP-1 users nationwide, and around 5.2% of women with obesity are prescribed a GLP-1 medication (compared to 4.2% of men)
